BNP Paribas Financial Markets’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-83
| Closed | -$301 | – | 3338 |
|
|
2023
Q1 | $301 | Buy |
83
+5
| +6% | +$18 | ﹤0.01% | 3112 |
|
|
2022
Q4 | $2.5K | Buy |
78
+46
| +144% | +$1.47K | ﹤0.01% | 3052 |
|
|
2022
Q3 | $1.35K | Sell |
32
-152
| -83% | -$6.43K | ﹤0.01% | 3678 |
|
|
2022
Q2 | $7.75K | Buy |
184
+38
| +26% | +$1.6K | ﹤0.01% | 3136 |
|
|
2022
Q1 | $9.92K | Sell |
146
-193
| -57% | -$13.1K | ﹤0.01% | 3230 |
|
|
2021
Q4 | $41.2K | Buy |
339
+54
| +19% | +$6.56K | ﹤0.01% | 3127 |
|
|
2021
Q3 | $40.1K | Buy |
285
+247
| +650% | +$34.7K | ﹤0.01% | 2966 |
|
|
2021
Q2 | $10.5K | Sell |
38
-94
| -71% | -$26K | ﹤0.01% | 3115 |
|
|
2021
Q1 | $28.1K | Sell |
132
-67
| -34% | -$14.3K | ﹤0.01% | 3142 |
|
|
2020
Q4 | $48.1K | Sell |
199
-34
| -15% | -$8.21K | ﹤0.01% | 2917 |
|
|
2020
Q3 | $24.5K | Buy |
233
+153
| +191% | +$16.1K | ﹤0.01% | 3135 |
|
|
2020
Q2 | $7.83K | Sell |
80
-131
| -62% | -$12.8K | ﹤0.01% | 3184 |
|
|
2020
Q1 | $15.8K | Buy |
211
+62
| +42% | +$4.65K | ﹤0.01% | 3343 |
|
|
2019
Q4 | $12.1K | Buy |
149
+34
| +30% | +$2.76K | ﹤0.01% | 3437 |
|
|
2019
Q3 | $14K | Buy |
115
+6
| +6% | +$729 | ﹤0.01% | 3443 |
|
|
2019
Q2 | $19.5K | Sell |
109
-39
| -26% | -$6.98K | ﹤0.01% | 3283 |
|
|
2019
Q1 | $23.7K | Buy |
148
+143
| +2,860% | +$22.9K | ﹤0.01% | 3261 |
|
|
2018
Q4 | $1.24K | Sell |
5
-4
| -44% | -$989 | ﹤0.01% | 3217 |
|
|
2018
Q3 | $2.13K | Hold |
9
| – | – | ﹤0.01% | 3579 |
|
|
2018
Q2 | $2.07K | Buy |
+9
| New | +$2.07K | ﹤0.01% | 3600 |
|